{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000000", "text": "# BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "section": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "page_from": null, "page_to": null, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "857d908af1323793ded0db4aeee586dd1717b278758011a9f8be6cb71f5fe0bd"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000001", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n1\n\nInterpretation of p53 Immunohistochemistry In Tubo-Ovarian\nCarcinoma: Guidelines for Reporting\nAuthor: Martin Köbel1\nCo-authors: W Glenn McCluggage2, C Blake Gilks3, Naveena Singh4\n1University of Calgary, Calgary, Canada; 2Belfast Health and Social Care Trust, Belfast, UK; 3Vanvouver General Hospital and University of British\nColumbia, Vancouver, Canada; 4Barts Health NHS trust, London, UK.\nBackground\n p53 immunohistochemistry (IHC) is an accurate, cheap and fast method to investigate\nTP53 mutation status [1].\n Historically, p53 IHC has been interpreted as negative or positive based on the\npercentage of stained tumor cell nuclei using variable cut-offs which range from 5 to\n50%.\n More recently, a tripartite interpretation has been suggested [2], wherein an\n“overexpressed or no expression (all or nothing)” nuclear staining pattern is highly\npredictive of underlying TP53 mutation while a normal/wild type pattern is not.\n Of note, rare cases with TP53 mutation rarely show cytoplasmic staining, and, about 5%\ncases have a wild type pattern [1].", "section": "Interpretation of p53 Immunohistochemistry In Tubo-Ovarian", "page_from": 1, "page_to": 1, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "8f603d0eb161f226abde81d3ba13761abfd5a7320fda36af62e3c929928060a7"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000002", "text": " Of note, rare cases with TP53 mutation rarely show cytoplasmic staining, and, about 5%\ncases have a wild type pattern [1].\n As a result p53 IHC can be interpreted as either “Normal” or “Abnormal”, as shown\nbelow.\np53 immunohistochemistry pattern and interpretation\nPattern\np53 IHC\nInterpretation\nTP53 mutation type\n% in HGSC\nTP53 MUTATION ABSENT\nWild type\nNormal\nNo mutation\n0\nTP53 MUTATION PRESENT\nOverexpression\nAbnormal\nNon-synonymous (missense); also in-\nframe deletion, splicing\n66%\nComplete absence/\nnull\nAbnormal\nIndels, stopgains, splicing mutations\n25%\nCytoplasmic\nAbnormal\nIndels and stopgains with disruption of\nthe nuclear localization domain\n4%\nWild type\nNormal*\nTruncating mutation\n5%\nHGSC- high-grade serous carcinoma", "section": "Interpretation of p53 Immunohistochemistry In Tubo-Ovarian", "page_from": 1, "page_to": 1, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "061a6a025c3751ab35cadf896e435aaf65cd1e5a80c8d7484e4fbaa4a046555c"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000003", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n2\n\n “Normal” indicates that there is no evidence of an underlying TP53 mutation, i.e. TP53 is\nwild type\no *exception for normal:  truncating mutations can be associated with wild type\npattern (see note)\n “Abnormal” indicates that there is evidence of TP53 mutation.\n Interpretation as negative/positive is ambiguous and therefore strongly discouraged.\n\nNOTE: High-grade serous carcinomas (HGSC) ubiquitously (i.e. 100%) harbor TP53\nmutations but only 95% show abnormal p53 staining.  In other words, 5% of HGSC show\nnormal p53 immunohistochemistry (wild type pattern) but still harbor a TP53 mutation [1].\nThese are truncating mutations, which are characterized by a late stopgain resulting in\ntranslation of truncated protein, which can be detected by most N-terminal directed\nantibodies.", "section": "Interpretation of p53 Immunohistochemistry In Tubo-Ovarian", "page_from": 2, "page_to": 2, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "a808151fb39f2b57409bd453307829901a85af402a0bbe6efa1c22174de0659b"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000004", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n3\n\nWild type pattern (Normal p53 IHC)\n The distribution of nuclear staining in a ‘wild type’ pattern ranges from a few positive\ncells to almost all cells staining, but with variable intensity.\n In general, the intensity and extent of nuclear staining is associated with the\nproliferation index, eg, basal keratinocytes of normal skin or epithelial cells of colonic\ncrypts bases show variable p53 staining while the mitotically inactive superficial\nkeratinocytes or luminal colonic epithelial cells are negative.\n Stromal fibroblasts and intratumoral lymphocytes also show wild type pattern and are\nused as intrinsic control (see examples below).\nFigure 1a. Wild type pattern in an\nendometrioid carcinoma with the majority of\ntumor cells being negative but some showing\nvariable intensity (only few strong).\nFigure 1b. Wild type pattern in a low-grade\nserous carcinoma with >80% of tumor cell\nnuclei staining with variable intensity (only\nfew strong). The staining is of similar intensity\nto that in  germinal centers (left Fig. 2).", "section": "Interpretation of p53 Immunohistochemistry In Tubo-Ovarian", "page_from": 3, "page_to": 3, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "0710e10185af99eebfc5c2da6c0176bdddf117b107d332a5b4d415f9038d5a75"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000005", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n4\n\nFigure 2a. Wild type pattern in a germinal\ncenter B-cells\nFigure 2b. Wild type pattern in normal\nsquamous epithelium\n\nFigure 3. Wild type patternin fallopian tubes", "section": "Interpretation of p53 Immunohistochemistry In Tubo-Ovarian", "page_from": 4, "page_to": 4, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "b943a710bfe7b1a37fbd742076711b5723f63830c7fa0649808944fdf666c0a6"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000006", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n5\n\nOverexpression (Abnormal p53 IHC)\n Overexpression is defined as strong nuclear staining in at least 80% of tumor cell\nnuclei (usually 100% tumor cell nuclei, the 80% cut-off accounts for technical artifacts\nand the rare mosaic pattern, see below).\n Overexpression is the most common (~66%) pattern observed in HGSC, almost certainly\nsignifying an underlying TP53 mutation.\n p53 overexpression is strongly associated with nonsynonymous (or missense) TP53\nmutations, however, in- frame deletions and splicing mutations can also result in this\npattern.\n These mutations interfere with MDM2 mediated ubiquitination resulting in massive\nnuclear accumulation of the p53 protein.\nFigure 3. Overexpression seen in two high-grade serous carcinomas. Virtually all tumor cell\nnuclei show strong staining intensity compared to the intrinsic control (stromal fibroblasts).", "section": "Interpretation of p53 Immunohistochemistry In Tubo-Ovarian", "page_from": 5, "page_to": 5, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "d3361e00dce7f16ed384de3852c296a4437811183d7951d263d3558b2400fbe6"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000007", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n6\n\nComplete absence or null pattern (Abnormal)\n Complete absence is defined as no staining in tumor cell nuclei in the presence of\n‘wild-type’, ie variable, staining in normal background cells (intrinsic control present).\nThe interpretation is similar to that of DNA mismatch repair gene protein expression.\n Complete absence is observed in ~25% of HGSC.\n Complete absence is almost certainly indicative of underlying TP53 mutation.\n The type of mutation includes indels, stopgains and splicing mutations.\n The former two result in a premature stopgain, in which the shorter mRNA is subjected\nto nonsense mediated decay resulting in no mRNA and therefore no translated protein.\nFigure 4. Complete absence in two high-grade serous carcinomas. No staining in tumor cell\nnuclei but the intrinsic stromal nuclear positive control is clearly visible.", "section": "Interpretation of p53 Immunohistochemistry In Tubo-Ovarian", "page_from": 6, "page_to": 6, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "a4182ad8c701584a7d0e056a719ba4d5533781d8eae1fc5c9720de2847ad8344"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000008", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n7\n\nCytoplasmic (Abnormal)\n Cytoplasmic staining is defined as predominant cytoplasmic staining in the absence of\nstrong nuclear staining in >80% of tumor cell nuclei, i.e. the nuclear staining can be\nabsent or weak and variable.\n The cytoplasmic pattern is seen in ~4% of high-grade serous carcinomas and is\nassociated with underlying TP53 mutation.\n The types of mutation include indel and stopgain with disruption of the nuclear\nlocalization domain.\n\nFigure 5. Cytoplasmic staining seen in two high-grade serous carcinomas. Note strong to\nmoderate cytoplasmic staining seen in the epithelial compartment but not in the intrinsic\ncontrol (stromal compartment).", "section": "Interpretation of p53 Immunohistochemistry In Tubo-Ovarian", "page_from": 7, "page_to": 7, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "762559845efa8d56f0cd30ab94cb94133496dbebcfcd1a28b1c0f00b05064ccc"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000009", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n8\n\nProblematic Areas in p53 Interpretation\n For diagnostic purposes it is currently more important to distinguish between presence\nand absence of the TP53 mutation, i.e. the distinction of normal versus abnormal p53\nimmunohistochemistry.\n The specific abnormal pattern may become important in the future with p53-targeted\ntherapies entering clinical trials.\n Herein, we focus on interpretational issues that commonly arise in the distinction\nbetween normal and the three abnormal patterns:\n\n1. Wild type pattern versus overexpression\na. “High” wild type staining due to high proliferation/strong staining\nb. “Low” overexpression due to antigen degradation, splicing mutations, or weak\nstaining\nc. Heterogeneous staining\n\n2. Wild type pattern versus complete absence\na. “Low” wild type pattern due to low proliferation, antigen degradation, or weak\nstaining\nb. Lack intrinsic control\nc. Occasional tumor cell staining in otherwise complete absence pattern\nd. True p53 IHC wild type high-grade serous carcinomas\n\n3. Wild type pattern versus cytoplasmic", "section": "Problematic Areas in p53 Interpretation", "page_from": 8, "page_to": 8, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "e0a576b3433846b1ea0afd15806112a902989aed3675f15e4973bdfe4a321928"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000010", "text": "b. Lack intrinsic control\nc. Occasional tumor cell staining in otherwise complete absence pattern\nd. True p53 IHC wild type high-grade serous carcinomas\n\n3. Wild type pattern versus cytoplasmic\na. Threshold for diagnosis of cytoplasmic staining is not well established\nb. Recognition of spurious cytoplasmic staining", "section": "Problematic Areas in p53 Interpretation", "page_from": 8, "page_to": 8, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "e1b0ae1b6e2d14c5e7ec70b1334397e3ca46f842678d6f67806d571eae2110cd"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000011", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n9\n\n1 - Wild type pattern versus overexpression (Fig. 6)\nFigure 6a. Reference wild type pattern\n\nFigure 6b: Reference overexpression\n\n1a. “High” wild type staining due to high proliferation or strong staining (Fig. 7a)\n Staining of overall strong intensity results in a larger proportion of nuclei being strongly\nstained, with potential for a ‘wild type’ pattern to be interpreted as overexpression.\n Staining remains variable and <80% nuclei should show strong staining.\n The level of staining in the intrinsic control should serve as a rough guide.\nFigure 7a. “High” wild type pattern in an endometrioid and low-grade serous tumor. The\nstaining shows variable intensity. Note,  only a minority of nuclei are stongly stained. The\nintrinsic control in the case on the right is indicating strong staining.", "section": "Problematic Areas in p53 Interpretation", "page_from": 9, "page_to": 9, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "10bf8f3e03b4bdf38d9463ecaadc227c5c5405a906723f2c072531b7b41e29aa"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000012", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n10\n\n1b. “Low” overexpression due to antigen degradation, splicing mutations, or weak staining\n(Fig. 7b)\n Staining of overall weak intensity results in a smaller proportion of nuclei being strongly\nstained, with potential for overexpression to be interpreted as a ‘wild type’ pattern.\n The majority of nuclei stain strongly but a significant proportion stain weakly or are\nnegative\n >80% nuclei should show strong staining.\n The level of staining in the intrinsic control should serve as a rough guide.\nFigure 7b. “Low” overexpression in two high-grade serous carcinomas appearing as so called\n“mosaic” pattern. The majority of nuclei staining strongly but a significant proportion being\nnegative (approaching 80% cut-off)\n\n1c. Heterogeneous staining (Fig 8)\n Heterogeneous staining is defined by the presence of more than one pattern.\n  It is rarely seen (<3%) in high-grade serous carcinomas, since TP53 mutations are an\nearly ancestral event and should be present in all tumor cells [3].\n This is most likely due to poor antigen preservation (i.e. delayed fixation), however,", "section": "Problematic Areas in p53 Interpretation", "page_from": 10, "page_to": 10, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "af0491b287deac37341b7dd48ce089f18efc4ae9b76acf679ea27709d50478f6"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000013", "text": "early ancestral event and should be present in all tumor cells [3].\n This is most likely due to poor antigen preservation (i.e. delayed fixation), however,\nalternative explanations, such as underlying splicing mutation with different effects on\np53 expression in different cells of the same tumor cannot not be excluded.\n In contrast, TP53 mutations are acquired during progression of other histotypes such as\nmucinous carcinoma [4]; here, heterogeneous p53 expression can be expected and", "section": "Problematic Areas in p53 Interpretation", "page_from": 10, "page_to": 10, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "79d0f32fcd1700db19c86b221562374763fd5af7d8ed5d4af9b8270823658c76"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000014", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n11\n\nshould be reported as such, e.g. p53 expression abnormal (heterogeneous with areas of\noverexpression and wild type pattern).\nFigure 8. Heterogeneous staining in the same high-grade serous carcinomas with an area\nbordering wild type pattern (left) and an area of typical overexpression (right).\n\nFigure 9a. High-grade serous carcinoma with\nheterogeneous staining: lower right =\noverexpression, upper left = wild type pattern.\nFigure 9b. Mucinous carcinoma with\nheterogeneous staining.", "section": "Problematic Areas in p53 Interpretation", "page_from": 11, "page_to": 11, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "021cc33d879503d266f5951f8d10aecd1d0bbac595c694502dc5a093a2954390"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000015", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n12\n\n2. Wild type pattern versus complete absence (Figure 10)\n Staining of overall weak intensity can result in absent nuclear staining in a large\nproportion or all nuclei, with potential for a ‘wild type’ pattern to be interpreted as\ncomplete absence.\n The level of staining in the intrinsic control should serve as a rough guide.\n A complete absence pattern should not be reported in the absence of a positive intrinsic\ncontrol of stromal cells and lymphocytes with variable but discernible nuclear staining.\n Examples are illustrated below in Figures 11-14.\nFigure 10a: Reference wild type pattern\n\nFigure 10b. Reference complete absence\nFigure 11 The same case of clear cell carcinoma stained on two platforms. Left: occasional\ntumor cell nuclei weakly stained (arrow) consistent with wild type pattern. Right: stronger\nstaining with more positivity but variable intensity.", "section": "Problematic Areas in p53 Interpretation", "page_from": 12, "page_to": 12, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "7527e13950034ef5061607bb2bf67e71e6b8149d9d1ee4e7666d436c0808f0a5"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000016", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n13\n\nFigure 12. Same high-grade serous carcinoma stained on two platforms. Left, there is no\npositive internal control, case is non interpretable, right, clear variable staining of internal\ncontrol clearly interpretable as complete absence\n\nFigure 12a. Non-interpretable due to lack of\ninternal control\nFigure 12a. Complete absence with scant\ninternal control (arrow)", "section": "Problematic Areas in p53 Interpretation", "page_from": 13, "page_to": 13, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "d2c5cc90999869a98b74bea22c223aeec68585d0dbba65bc7a558fc956900a38"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000017", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n14\n\nFigure 13.  Complete absence in high-grade serous carcinoma from cell block. Left: low power\n(10x) showing abundance of normal inflammatory cells giving the impression of wild type\npattern but on high power (20x, right), the actual tumor cells are completely negative.\n\nFig. 14a Occasional tumor cells (arrow)\nstaining in an otherwise complete absence\nhigh-grade serous carcinoma. This may be due\nto non-specific staining and is to be\ndistinguished from the right.\nFig. 14a Occasional tumor cells (arrow)\nstaining in a high-grade serous carcinoma can\nalso be interpreted as wild type pattern. Note,\n5% of high-grade serous carcinomas (those\nwith truncating mutations) show p53 wild type\npattern.", "section": "Problematic Areas in p53 Interpretation", "page_from": 14, "page_to": 14, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "ff5f9a4145d8332c1cff75cec6a6f57e19308b257f3d3bc518523a9591a81053"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000018", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n15\n\n4. Wild type pattern versus cytoplasmic (Figure 15)\n Weak cytoplasmic staining may be seen in cases with otherwise clearly interpretable\nnuclear staining.\n In order to reflect an underlying mutation the intensity of cytoplasmic staining should\nbe at least moderate and unaccompanied by any spurious cytoplasmic staining of the\nbackground normal cells.\n The nuclear staining intensity in cytoplasmic pattern can be absent or variable but not\nstrong diffuse.\n\nFigure 15a: Reference wild type pattern\n\nFigure 15b. Reference cytoplasmic\nFigure 16a. High wild type pattern with weak\ncytoplasmic (background) staining but\ninterpretable variable nuclear staining.\nFigure 16b. Cytoplasmic pattern with\nmoderate cytoplasmic staining and nonspecific\nnuclear staining", "section": "Problematic Areas in p53 Interpretation", "page_from": 15, "page_to": 15, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "e7c959f16b8319e39fa7c64de0ed49ee739dd95d3c12956d5cda9b47ee7f39fd"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000019", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n16\n\nFigure 17a. Overexpression pattern in high-\ngrade serous carcinoma showing an area of\nspurious artificial cytoplasmic staining (upper\nleft).\nFigure 17b. Overexpression pattern in high-\ngrade serous carcinoma showing an extensive\nspurious artificial cytoplasmic staining\nincluding the stromal component.", "section": "Problematic Areas in p53 Interpretation", "page_from": 16, "page_to": 16, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "8760833ab0d02769de2bf18f633d5f8d24578d1557f2b2290e1d0d46959aafb9"}
{"doc_id": "bagp-ukneqas-project-p53-interpretation-guide-2016__v00000000", "chunk_id": "000020", "text": "Guidance document: p53 IHC reporting in tubo-ovarian carcinoma version 1.0, dated October 2016\n17", "section": "Problematic Areas in p53 Interpretation", "page_from": 17, "page_to": 17, "display_name": "BAGP-UKNEQAS-project-p53-interpretation-guide-2016", "version": "v00000000", "created_at": "2025-11-28T06:07:19", "hash": "5eb1f130f5c99e1a48e664fd4fc29ce3f3074a3742efb003fbae314104566448"}
